Immunopharmacologic effects of immunosuppressive agents explored by a new effector monocyte generation assay.
Ishibashi
M
M
Department of Urology, Osaka University Hospital, Japan.
Jiang
S
S
Kokado
Y
Y
Takahara
S
S
Sonoda
T
T
D001379:Azathioprine / Q000494:pharmacology / Q000627:therapeutic use; D002478:Cells, Cultured; D003114:Colony-Forming Units Assay; D003524:Cyclosporins / Q000494:pharmacology / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006085:Graft Survival; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016030:Kidney Transplantation; D009000:Monocytes / Q000187:drug effects* / Q000276:immunology; D011239:Prednisolone / Q000494:pharmacology / Q000627:therapeutic use; D011725:Pyridines / Q000494:pharmacology; D012263:Ribonucleosides / Q000494:pharmacology / Q000627:therapeutic use; D016559:Tacrolimus; D014184:Transplantation, Homologous
D003524:Cyclosporins; D006146:Guanidines; D007166:Immunosuppressive Agents; D011725:Pyridines; D012263:Ribonucleosides; C010052:mizoribine; D011239:Prednisolone; D001379:Azathioprine; C037258:gusperimus; D016559:Tacrolimus